Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

MOPH Mobile Application

 

“Haak bi Idak… Wajebna nfidik”

Under the theme “Haak bi Idak… Wajebna nfidik”, the minister of Public Health Ali Hasan Khalil launched this afternoon the first mobile application within the national E-Health programme. This app aims at providing general services through the dissemination of information related to the services provided by the Ministry of Public Health and the way to access them with modern ICT and social media.

The Director of the national E-Health programme Mrs. Lina Abou Mrad introduced the goals and applications of the programme that grants every citizen the right to access the suitable information from the administration to get the required service. The application enables the citizen to keep informed on the prices of registered drugs and the conditions of benefiting from the drugs provided by the Ministry for chronic or incurable diseases … a guide for the governmental and private hospitals, the names of the inspection doctors working for them, the primary health care centers, the awareness campaigns of the ministry, the section of complaints, the links to the website, the sanitary materials uploaded to You Tube and all the activities of the ministry… in the best and fastest possible means. It activates as well the accountability through the adoption of a procedure to lodge complaints.

The head of Medical Professions Department Antoine Romanos then introduced projects to enhance and facilitate the procedures at the ministry through this application, most important of which: the improvement of the conduct of procedures and the related regulations, the adoption of transparency to improve the public service, a better understanding of the citizens’ needs, the simplification of procedures to end the unnecessary or expensive forms of regulation, the use of the ICT STOP SHOP, the review of the rules and regulations to keep up with the administrative development and the introduction of the ONE stop Shop for the administrative transactions…

Minister Khalil noted that the meeting is to renew the confidence that has always existed in the state and institutions and their ability to accomplish great achievements. This is one the achievements of the Ministry of Public health’s team, administrators and employees. However it was clear that when the idea of the introduction of this app was advanced for the service of the Lebanese citizen, a team of administrators was fully ready. Khalil commended the role of Mrs. Abou Mrad and her commitment to provide all the necessary data for the application.

Minister Khalil handed out certificates of recognition to those who contributed in the completion of the work.
 
To download the mobile app:
 
On
 Google Play or  App Store
OR  For more information:
 
    4
    ...
ATC Name B/G Ingredients Dosage Form Price
L02BB03 BICALUTAMIDE BIOGARAN G Bicalutamide - 50mg 50mg Tablet, coated 4,315,078 L.L
L02BB03 BICALUTAMIDE ACCORD G Bicalutamide - 50mg 50mg Tablet, film coated 1,382,814 L.L
L01XG01 BORTEZOMIB SPC G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 15,743,401 L.L
L01XG01 BORTEZOMIB SHILPA G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder 9,902,420 L.L
L01XG01 BORTEZOMIB NEAPOLIS G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder for solution 14,169,600 L.L
L01XG01 BORTEZOMIB GP PHARM G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 13,007,658 L.L
L01XG01 BORTEZOMIB ACCORD G Bortezomib - 3.5mg 3.5mg Injectable powder for solution 13,007,658 L.L
L01XG01 BORCADE G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder 11,020,381 L.L
L01XG01 BORCADE G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder 11,020,381 L.L
L01FX07 BLINCYTO BioTech Blinatumomab - 35mcg 35mcg Injectable lyophilised powder for solution+stabilizer 239,484,334 L.L
L01FG01 BIVASTINA 100 BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 12,021,318 L.L
L01FG01 BIVASTINA 100 BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 22,840,337 L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable solution 14,719,570 L.L
L01FG01 BIVASTINA 400 BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 53,111,763 L.L
L01FG01 BIVASTINA 400 BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 92,353,609 L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable solution 49,744,595 L.L
L01FF04 BAVENCIO BioTech Avelumab - 200mg/10ml 200mg/10ml Injectable concentrate for solution 104,075,577 L.L
L01FB01 BESPONSA FOR INJECTION BioTech Inotuzumab Ozogamicin - 0.9mg 0.9mg Injectable powder for suspension 921,176,511 L.L
L01EC03 BRAFTOVI BioTech Encorafenib - 75mg 75mg Capsule, hard 149,227,143 L.L
L01EC03 BRAFTOVI BioTech Encorafenib - 50mg 50mg Capsule, hard 70,084,833 L.L
L01EA04 BOSULIF B Bosutinib - 500mg 500mg Tablet, film coated 154,453,246 L.L
L01EA04 BOSULIF B Bosutinib - 400mg 400mg Tablet, film coated 123,564,667 L.L
L01EA04 BOSULIF B Bosutinib - 100mg 100mg Tablet, film coated 35,663,747 L.L
L01DC01 BLEO-CELL G Bleomycin (sulfate) - 15mg 15mg Injectable powder for solution 3,817,857 L.L
L01DC01 BLEOCIN B Bleomycin (sulfate) - 15U 15U Injectable lyophilised powder for solution 2,109,833 L.L
L01AA09 BENDAVIVAL G Bendamustine HCl - 100mg 100mg Injectable concentrated powder for solution 26,072,618 L.L
L01AA09 BENDAMUSTINE MEDAC G Bendamustine HCl - 2.5mg/ml (100mg) 2.5mg/ml Injectable powder for concentrate for solution 16,887,989 L.L
L01AA09 BENDAMUSTINE HYDROCHLORIDE GP PHARM G Bendamustine HCl - 100mg/50ml 100mg/50ml Injectable powder for concentrate for solution 78,439,178 L.L
L01AA09 BENDAMUSTINE HYDROCHLORIDE G Bendamustine HCl - 100mg/50ml 100mg/50ml Injectable powder for concentrate for solution 78,439,178 L.L
L01AA09 BENDAMUSTINE MEDAC G Bendamustine HCl - 2.5mg/ml (25mg) 2.5mg/ml Injectable powder for concentrate for solution 24,934,922 L.L
    4
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025